Core Biogenesis
French tech company | Builders Republic
About
Biotech company that produces plant-based recombinant proteins for cell therapy, regenerative medicine, and cosmetics — including FGF-2 TOP® (thermostable fibroblast growth factor stabilized via oleosomes), available from research-grade to GMP-compliant pharmaceutical standards.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series A
- Founded
- 2020
- City
- STRASBOURG
- Region
- IDF
- Tracked rounds
- 2
- Amount raised
- 13 M€ raised since 2020
Funding rounds
- Series A — 2022
- Series A — 2020
Investors
- Blue Horizon Ventures
- Entrepreneur First
- Plug & Play
- Thia Ventures
- XAnge